Your browser doesn't support javascript.
loading
BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.
Randall, Michael P; Egolf, Laura E; Vaksman, Zalman; Samanta, Minu; Tsang, Matthew; Groff, David; Evans, J Perry; Rokita, Jo Lynne; Layeghifard, Mehdi; Shlien, Adam; Maris, John M; Diskin, Sharon J; Bosse, Kristopher R.
Afiliación
  • Randall MP; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Egolf LE; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Vaksman Z; Cell and Molecular Biology Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Samanta M; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Tsang M; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Groff D; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Evans JP; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Rokita JL; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Layeghifard M; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Shlien A; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, PA 19104, USA.
  • Maris JM; Division of Neurosurgery, Children's Hospital of Philadelphia, PA 19104, USA.
  • Diskin SJ; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Bosse KR; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
bioRxiv ; 2023 Feb 03.
Article en En | MEDLINE | ID: mdl-36778420

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos